nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—TYMS—ovarian cancer	0.289	1	CbGaD
Capecitabine—colon cancer—ovarian cancer	0.272	0.515	CtDrD
Capecitabine—breast cancer—ovarian cancer	0.256	0.485	CtDrD
Capecitabine—DPYD—Nucleotide metabolism—NME2—ovarian cancer	0.00172	0.0602	CbGpPWpGaD
Capecitabine—DPYD—uterine cervix—ovarian cancer	0.00167	0.0497	CbGeAlD
Capecitabine—CDA—uterine cervix—ovarian cancer	0.0016	0.0479	CbGeAlD
Capecitabine—DPYD—decidua—ovarian cancer	0.00159	0.0474	CbGeAlD
Capecitabine—CDA—Nucleotide metabolism—NME2—ovarian cancer	0.00153	0.0537	CbGpPWpGaD
Capecitabine—CDA—decidua—ovarian cancer	0.00153	0.0456	CbGeAlD
Capecitabine—CDA—endometrium—ovarian cancer	0.00145	0.0433	CbGeAlD
Capecitabine—DPYD—uterus—ovarian cancer	0.00139	0.0415	CbGeAlD
Capecitabine—TYMP—myometrium—ovarian cancer	0.00124	0.037	CbGeAlD
Capecitabine—TYMP—Nucleotide metabolism—NME2—ovarian cancer	0.00122	0.0429	CbGpPWpGaD
Capecitabine—DPYD—bone marrow—ovarian cancer	0.00118	0.0352	CbGeAlD
Capecitabine—DPYD—female gonad—ovarian cancer	0.00114	0.0339	CbGeAlD
Capecitabine—CDA—bone marrow—ovarian cancer	0.00113	0.0339	CbGeAlD
Capecitabine—CDA—vagina—ovarian cancer	0.00109	0.0324	CbGeAlD
Capecitabine—DPYD—testis—ovarian cancer	0.00101	0.0301	CbGeAlD
Capecitabine—DPYD—Pyrimidine metabolism—TYMS—ovarian cancer	0.001	0.0351	CbGpPWpGaD
Capecitabine—CDA—testis—ovarian cancer	0.000969	0.0289	CbGeAlD
Capecitabine—TYMP—uterine cervix—ovarian cancer	0.000965	0.0288	CbGeAlD
Capecitabine—TYMP—decidua—ovarian cancer	0.000919	0.0275	CbGeAlD
Capecitabine—TYMS—Docetaxel—Paclitaxel—ovarian cancer	0.000895	0.472	CbGdCrCtD
Capecitabine—CDA—Pyrimidine metabolism—TYMS—ovarian cancer	0.000892	0.0313	CbGpPWpGaD
Capecitabine—TYMP—endometrium—ovarian cancer	0.000873	0.0261	CbGeAlD
Capecitabine—TYMS—uterine cervix—ovarian cancer	0.000828	0.0247	CbGeAlD
Capecitabine—TYMP—uterus—ovarian cancer	0.000804	0.024	CbGeAlD
Capecitabine—DPYD—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.000776	0.0272	CbGpPWpGaD
Capecitabine—TYMS—endometrium—ovarian cancer	0.000749	0.0224	CbGeAlD
Capecitabine—DPYD—lymph node—ovarian cancer	0.00073	0.0218	CbGeAlD
Capecitabine—TYMP—female reproductive system—ovarian cancer	0.000723	0.0216	CbGeAlD
Capecitabine—TYMP—Pyrimidine metabolism—TYMS—ovarian cancer	0.000713	0.025	CbGpPWpGaD
Capecitabine—CDA—lymph node—ovarian cancer	0.000702	0.021	CbGeAlD
Capecitabine—TYMS—gonad—ovarian cancer	0.000694	0.0207	CbGeAlD
Capecitabine—CDA—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.000691	0.0242	CbGpPWpGaD
Capecitabine—TYMP—bone marrow—ovarian cancer	0.000682	0.0204	CbGeAlD
Capecitabine—TYMP—female gonad—ovarian cancer	0.000658	0.0196	CbGeAlD
Capecitabine—TYMP—vagina—ovarian cancer	0.000654	0.0195	CbGeAlD
Capecitabine—TYMS—Nucleotide metabolism—NME2—ovarian cancer	0.000626	0.0219	CbGpPWpGaD
Capecitabine—CES1—female reproductive system—ovarian cancer	0.000624	0.0186	CbGeAlD
Capecitabine—TYMS—female reproductive system—ovarian cancer	0.00062	0.0185	CbGeAlD
Capecitabine—CES1—Irinotecan Pathway—APC—ovarian cancer	0.000594	0.0208	CbGpPWpGaD
Capecitabine—TYMS—bone marrow—ovarian cancer	0.000586	0.0175	CbGeAlD
Capecitabine—TYMP—testis—ovarian cancer	0.000583	0.0174	CbGeAlD
Capecitabine—CES1—female gonad—ovarian cancer	0.000568	0.017	CbGeAlD
Capecitabine—TYMS—female gonad—ovarian cancer	0.000564	0.0169	CbGeAlD
Capecitabine—TYMS—vagina—ovarian cancer	0.000561	0.0168	CbGeAlD
Capecitabine—TYMP—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.000553	0.0194	CbGpPWpGaD
Capecitabine—CES1—testis—ovarian cancer	0.000504	0.015	CbGeAlD
Capecitabine—TYMS—testis—ovarian cancer	0.000501	0.015	CbGeAlD
Capecitabine—CES1—E2F transcription factor network—RBL2—ovarian cancer	0.000492	0.0172	CbGpPWpGaD
Capecitabine—TYMS—G1/S-Specific Transcription—CCNE1—ovarian cancer	0.000489	0.0171	CbGpPWpGaD
Capecitabine—TYMS—Paclitaxel—Docetaxel—ovarian cancer	0.000447	0.236	CbGdCrCtD
Capecitabine—TYMP—lymph node—ovarian cancer	0.000423	0.0126	CbGeAlD
Capecitabine—CES1—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.000407	0.0143	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.000404	0.0142	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CDH1—ovarian cancer	0.000392	0.0138	CbGpPWpGaD
Capecitabine—DPYD—Nucleotide metabolism—TYMS—ovarian cancer	0.00039	0.0137	CbGpPWpGaD
Capecitabine—CES1—lymph node—ovarian cancer	0.000365	0.0109	CbGeAlD
Capecitabine—TYMS—lymph node—ovarian cancer	0.000363	0.0108	CbGeAlD
Capecitabine—CDA—Nucleotide metabolism—TYMS—ovarian cancer	0.000347	0.0122	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—RBL2—ovarian cancer	0.000341	0.012	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—ERBB2—ovarian cancer	0.000331	0.0116	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CXCL8—ovarian cancer	0.000314	0.011	CbGpPWpGaD
Capecitabine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.000313	0.011	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—PPP2R1A—ovarian cancer	0.00031	0.0109	CbGpPWpGaD
Capecitabine—TYMS—Vincristine—Vinorelbine—ovarian cancer	0.000307	0.162	CbGdCrCtD
Capecitabine—TYMP—Bladder Cancer—CCND1—ovarian cancer	0.000293	0.0103	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—CCNE1—ovarian cancer	0.000288	0.0101	CbGpPWpGaD
Capecitabine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.000285	0.00998	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—TYMS—ovarian cancer	0.000278	0.00973	CbGpPWpGaD
Capecitabine—CYP2C9—female reproductive system—ovarian cancer	0.000271	0.00809	CbGeAlD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000257	0.00901	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—VEGFA—ovarian cancer	0.000255	0.00894	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—BRCA1—ovarian cancer	0.000251	0.00879	CbGpPWpGaD
Capecitabine—TYMS—Vinblastine—Vinorelbine—ovarian cancer	0.000247	0.13	CbGdCrCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000242	0.00847	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—MYC—ovarian cancer	0.000235	0.00822	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—MAPK1—ovarian cancer	0.00023	0.00804	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—EGFR—ovarian cancer	0.000229	0.00804	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000229	0.00803	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CCNE1—ovarian cancer	0.00022	0.0077	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—TYMS—ovarian cancer	0.000216	0.00757	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—RBL2—ovarian cancer	0.000209	0.00732	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.000197	0.00692	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.000197	0.00691	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—TP53—ovarian cancer	0.000193	0.00675	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TOP1—ovarian cancer	0.000189	0.00663	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—HRAS—ovarian cancer	0.000184	0.00646	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000183	0.00642	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—BRCA1—ovarian cancer	0.000174	0.0061	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—SLC5A5—ovarian cancer	0.000166	0.0058	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000165	0.0058	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—SKP2—ovarian cancer	0.000165	0.00578	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RSF1—ovarian cancer	0.000162	0.00569	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—SLC2A1—ovarian cancer	0.00016	0.0056	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NME2—ovarian cancer	0.000156	0.00547	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CCNE1—ovarian cancer	0.000153	0.00534	CbGpPWpGaD
Capecitabine—CYP2C9—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000145	0.00507	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—HNF1B—ovarian cancer	0.000143	0.00503	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NME2—ovarian cancer	0.000139	0.00487	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—SKP2—ovarian cancer	0.000139	0.00487	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000135	0.00474	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.000133	0.00464	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—PPP2R1A—ovarian cancer	0.000119	0.00418	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDKN1B—ovarian cancer	0.000114	0.00399	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NME2—ovarian cancer	0.000111	0.0039	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—CCNE1—ovarian cancer	0.000111	0.00388	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND2—ovarian cancer	0.000106	0.00373	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYTB—ovarian cancer	0.000101	0.00352	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	0.0001	0.00352	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	9.42e-05	0.0033	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—ovarian cancer	9.38e-05	0.00329	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	9.33e-05	0.00327	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYTB—ovarian cancer	8.96e-05	0.00314	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—BRIP1—ovarian cancer	8.79e-05	0.00308	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPP1CC—ovarian cancer	8.79e-05	0.00308	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYC—ovarian cancer	8.72e-05	0.00306	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	8.61e-05	0.00302	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RAD51C—ovarian cancer	8.53e-05	0.00299	CbGpPWpGaD
Capecitabine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	8.5e-05	0.00298	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	8.34e-05	0.00292	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	8.1e-05	0.00284	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	8.07e-05	0.00283	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN1B—ovarian cancer	7.91e-05	0.00277	CbGpPWpGaD
Capecitabine—CDA—Metabolism—BRIP1—ovarian cancer	7.83e-05	0.00275	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPP1CC—ovarian cancer	7.83e-05	0.00275	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RBL2—ovarian cancer	7.66e-05	0.00268	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PPP1CC—ovarian cancer	7.46e-05	0.00261	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	7.3e-05	0.00256	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—CYP1B1—ovarian cancer	7.23e-05	0.00253	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYTB—ovarian cancer	7.17e-05	0.00251	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	7.07e-05	0.00248	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	7.07e-05	0.00248	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	6.87e-05	0.00241	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RBL2—ovarian cancer	6.85e-05	0.0024	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	6.55e-05	0.0023	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPP1CC—ovarian cancer	6.26e-05	0.0022	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—BRIP1—ovarian cancer	6.26e-05	0.0022	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	6.25e-05	0.00219	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	6.16e-05	0.00216	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYC—ovarian cancer	6.05e-05	0.00212	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—YAP1—ovarian cancer	5.9e-05	0.00207	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—CDKN1B—ovarian cancer	5.74e-05	0.00201	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NME2—ovarian cancer	5.69e-05	0.00199	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	5.39e-05	0.00189	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	5.26e-05	0.00184	CbGpPWpGaD
Capecitabine—CDA—Metabolism—YAP1—ovarian cancer	5.25e-05	0.00184	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—SKP2—ovarian cancer	5.1e-05	0.00179	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	5.09e-05	0.00178	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.06e-05	0.00177	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	4.83e-05	0.00169	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—FASN—ovarian cancer	4.81e-05	0.00168	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC5A5—ovarian cancer	4.73e-05	0.00166	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND1—ovarian cancer	4.61e-05	0.00162	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MLH1—ovarian cancer	4.61e-05	0.00161	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC2A1—ovarian cancer	4.57e-05	0.0016	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—SKP2—ovarian cancer	4.56e-05	0.0016	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—ovarian cancer	4.39e-05	0.00154	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP1B1—ovarian cancer	4.38e-05	0.00153	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	4.32e-05	0.00151	CbGpPWpGaD
Capecitabine—CDA—Metabolism—FASN—ovarian cancer	4.28e-05	0.0015	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC5A5—ovarian cancer	4.21e-05	0.00148	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—YAP1—ovarian cancer	4.2e-05	0.00147	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC2A1—ovarian cancer	4.07e-05	0.00143	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	3.95e-05	0.00139	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND2—ovarian cancer	3.91e-05	0.00137	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP1B1—ovarian cancer	3.9e-05	0.00137	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPP2R1A—ovarian cancer	3.88e-05	0.00136	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CHEK2—ovarian cancer	3.73e-05	0.00131	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—ovarian cancer	3.7e-05	0.0013	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	3.68e-05	0.00129	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYTB—ovarian cancer	3.67e-05	0.00128	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	3.66e-05	0.00128	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ABCB1—ovarian cancer	3.6e-05	0.00126	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	3.59e-05	0.00126	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TYMS—ovarian cancer	3.54e-05	0.00124	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	3.49e-05	0.00122	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BRCA1—ovarian cancer	3.49e-05	0.00122	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND2—ovarian cancer	3.49e-05	0.00122	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPP2R1A—ovarian cancer	3.46e-05	0.00121	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	3.46e-05	0.00121	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—FASN—ovarian cancer	3.42e-05	0.0012	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCNE1—ovarian cancer	3.42e-05	0.0012	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	3.37e-05	0.00118	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC5A5—ovarian cancer	3.37e-05	0.00118	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PPP2R1A—ovarian cancer	3.29e-05	0.00115	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC2A1—ovarian cancer	3.25e-05	0.00114	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PTEN—ovarian cancer	3.24e-05	0.00113	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ABCB1—ovarian cancer	3.21e-05	0.00113	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—BRIP1—ovarian cancer	3.2e-05	0.00112	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPP1CC—ovarian cancer	3.2e-05	0.00112	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BRCA2—ovarian cancer	3.16e-05	0.00111	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TYMS—ovarian cancer	3.16e-05	0.00111	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP1B1—ovarian cancer	3.12e-05	0.00109	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCNE1—ovarian cancer	3.06e-05	0.00107	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	3.05e-05	0.00107	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—BIRC5—ovarian cancer	3.02e-05	0.00106	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.88e-05	0.00101	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CAV1—ovarian cancer	2.85e-05	0.001	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.8e-05	0.000982	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPP2R1A—ovarian cancer	2.77e-05	0.000969	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.74e-05	0.000961	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.74e-05	0.000961	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BIRC5—ovarian cancer	2.7e-05	0.000947	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	2.69e-05	0.000943	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	2.65e-05	0.00093	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TERT—ovarian cancer	2.62e-05	0.000917	CbGpPWpGaD
Capecitabine—Urinary tract infection—Epirubicin—ovarian cancer	2.61e-05	0.000218	CcSEcCtD
Capecitabine—Conjunctivitis—Epirubicin—ovarian cancer	2.61e-05	0.000218	CcSEcCtD
Capecitabine—Dysuria—Doxorubicin—ovarian cancer	2.6e-05	0.000218	CcSEcCtD
Capecitabine—Neutropenia—Doxorubicin—ovarian cancer	2.6e-05	0.000218	CcSEcCtD
Capecitabine—Decreased appetite—Paclitaxel—ovarian cancer	2.6e-05	0.000218	CcSEcCtD
Capecitabine—DPYD—Metabolism—PIK3CG—ovarian cancer	2.6e-05	0.000911	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.59e-05	0.000907	CbGpPWpGaD
Capecitabine—Dry mouth—Docetaxel—ovarian cancer	2.59e-05	0.000217	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	2.59e-05	0.000217	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	2.58e-05	0.000216	CcSEcCtD
Capecitabine—Fatigue—Paclitaxel—ovarian cancer	2.58e-05	0.000216	CcSEcCtD
Capecitabine—TYMP—Metabolism—ABCB1—ovarian cancer	2.57e-05	0.0009	CbGpPWpGaD
Capecitabine—Constipation—Paclitaxel—ovarian cancer	2.56e-05	0.000214	CcSEcCtD
Capecitabine—Pain—Paclitaxel—ovarian cancer	2.56e-05	0.000214	CcSEcCtD
Capecitabine—Haematuria—Epirubicin—ovarian cancer	2.56e-05	0.000214	CcSEcCtD
Capecitabine—Confusional state—Docetaxel—ovarian cancer	2.56e-05	0.000214	CcSEcCtD
Capecitabine—CDA—Metabolism—CAV1—ovarian cancer	2.54e-05	0.000891	CbGpPWpGaD
Capecitabine—Photosensitivity reaction—Doxorubicin—ovarian cancer	2.54e-05	0.000213	CcSEcCtD
Capecitabine—Hepatobiliary disease—Epirubicin—ovarian cancer	2.54e-05	0.000213	CcSEcCtD
Capecitabine—Oedema—Docetaxel—ovarian cancer	2.54e-05	0.000212	CcSEcCtD
Capecitabine—Weight increased—Doxorubicin—ovarian cancer	2.53e-05	0.000212	CcSEcCtD
Capecitabine—Epistaxis—Epirubicin—ovarian cancer	2.53e-05	0.000212	CcSEcCtD
Capecitabine—TYMP—Metabolism—TYMS—ovarian cancer	2.52e-05	0.000884	CbGpPWpGaD
Capecitabine—Infection—Docetaxel—ovarian cancer	2.52e-05	0.000211	CcSEcCtD
Capecitabine—Weight decreased—Doxorubicin—ovarian cancer	2.52e-05	0.000211	CcSEcCtD
Capecitabine—Hyperglycaemia—Doxorubicin—ovarian cancer	2.51e-05	0.00021	CcSEcCtD
Capecitabine—Agranulocytosis—Epirubicin—ovarian cancer	2.5e-05	0.00021	CcSEcCtD
Capecitabine—Pneumonia—Doxorubicin—ovarian cancer	2.5e-05	0.000209	CcSEcCtD
Capecitabine—Shock—Docetaxel—ovarian cancer	2.5e-05	0.000209	CcSEcCtD
Capecitabine—Nervous system disorder—Docetaxel—ovarian cancer	2.49e-05	0.000208	CcSEcCtD
Capecitabine—Thrombocytopenia—Docetaxel—ovarian cancer	2.48e-05	0.000208	CcSEcCtD
Capecitabine—Infestation—Doxorubicin—ovarian cancer	2.48e-05	0.000208	CcSEcCtD
Capecitabine—Infestation NOS—Doxorubicin—ovarian cancer	2.48e-05	0.000208	CcSEcCtD
Capecitabine—Tachycardia—Docetaxel—ovarian cancer	2.48e-05	0.000207	CcSEcCtD
Capecitabine—Feeling abnormal—Paclitaxel—ovarian cancer	2.47e-05	0.000207	CcSEcCtD
Capecitabine—Skin disorder—Docetaxel—ovarian cancer	2.46e-05	0.000206	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	2.46e-05	0.000206	CcSEcCtD
Capecitabine—Bradycardia—Epirubicin—ovarian cancer	2.45e-05	0.000205	CcSEcCtD
Capecitabine—Gastrointestinal pain—Paclitaxel—ovarian cancer	2.45e-05	0.000205	CcSEcCtD
Capecitabine—Renal failure—Doxorubicin—ovarian cancer	2.44e-05	0.000204	CcSEcCtD
Capecitabine—Neuropathy peripheral—Doxorubicin—ovarian cancer	2.43e-05	0.000204	CcSEcCtD
Capecitabine—Haemoglobin—Epirubicin—ovarian cancer	2.42e-05	0.000203	CcSEcCtD
Capecitabine—Stomatitis—Doxorubicin—ovarian cancer	2.42e-05	0.000203	CcSEcCtD
Capecitabine—Jaundice—Doxorubicin—ovarian cancer	2.42e-05	0.000203	CcSEcCtD
Capecitabine—Anorexia—Docetaxel—ovarian cancer	2.42e-05	0.000203	CcSEcCtD
Capecitabine—Rhinitis—Epirubicin—ovarian cancer	2.41e-05	0.000202	CcSEcCtD
Capecitabine—Urinary tract infection—Doxorubicin—ovarian cancer	2.41e-05	0.000202	CcSEcCtD
Capecitabine—Conjunctivitis—Doxorubicin—ovarian cancer	2.41e-05	0.000202	CcSEcCtD
Capecitabine—Haemorrhage—Epirubicin—ovarian cancer	2.41e-05	0.000202	CcSEcCtD
Capecitabine—Hepatitis—Epirubicin—ovarian cancer	2.41e-05	0.000202	CcSEcCtD
Capecitabine—Hypoaesthesia—Epirubicin—ovarian cancer	2.4e-05	0.000201	CcSEcCtD
Capecitabine—Pharyngitis—Epirubicin—ovarian cancer	2.39e-05	0.0002	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.38e-05	0.000834	CbGpPWpGaD
Capecitabine—Urinary tract disorder—Epirubicin—ovarian cancer	2.38e-05	0.000199	CcSEcCtD
Capecitabine—Urticaria—Paclitaxel—ovarian cancer	2.38e-05	0.000199	CcSEcCtD
Capecitabine—Oedema peripheral—Epirubicin—ovarian cancer	2.37e-05	0.000199	CcSEcCtD
Capecitabine—Hypotension—Docetaxel—ovarian cancer	2.37e-05	0.000199	CcSEcCtD
Capecitabine—Haematuria—Doxorubicin—ovarian cancer	2.37e-05	0.000198	CcSEcCtD
Capecitabine—Connective tissue disorder—Epirubicin—ovarian cancer	2.37e-05	0.000198	CcSEcCtD
Capecitabine—Abdominal pain—Paclitaxel—ovarian cancer	2.37e-05	0.000198	CcSEcCtD
Capecitabine—Body temperature increased—Paclitaxel—ovarian cancer	2.37e-05	0.000198	CcSEcCtD
Capecitabine—Urethral disorder—Epirubicin—ovarian cancer	2.36e-05	0.000198	CcSEcCtD
Capecitabine—Hepatobiliary disease—Doxorubicin—ovarian cancer	2.35e-05	0.000197	CcSEcCtD
Capecitabine—Epistaxis—Doxorubicin—ovarian cancer	2.34e-05	0.000196	CcSEcCtD
Capecitabine—Visual impairment—Epirubicin—ovarian cancer	2.32e-05	0.000194	CcSEcCtD
Capecitabine—Agranulocytosis—Doxorubicin—ovarian cancer	2.32e-05	0.000194	CcSEcCtD
Capecitabine—CDA—Metabolism—PIK3CG—ovarian cancer	2.32e-05	0.000812	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	2.31e-05	0.000194	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.3e-05	0.000807	CbGpPWpGaD
Capecitabine—Insomnia—Docetaxel—ovarian cancer	2.29e-05	0.000192	CcSEcCtD
Capecitabine—DPYD—Metabolism—PIK3CD—ovarian cancer	2.28e-05	0.000801	CbGpPWpGaD
Capecitabine—Paraesthesia—Docetaxel—ovarian cancer	2.28e-05	0.000191	CcSEcCtD
Capecitabine—Erythema multiforme—Epirubicin—ovarian cancer	2.28e-05	0.000191	CcSEcCtD
Capecitabine—Bradycardia—Doxorubicin—ovarian cancer	2.27e-05	0.00019	CcSEcCtD
Capecitabine—Dyspnoea—Docetaxel—ovarian cancer	2.26e-05	0.000189	CcSEcCtD
Capecitabine—Eye disorder—Epirubicin—ovarian cancer	2.25e-05	0.000189	CcSEcCtD
Capecitabine—Tinnitus—Epirubicin—ovarian cancer	2.25e-05	0.000188	CcSEcCtD
Capecitabine—Haemoglobin—Doxorubicin—ovarian cancer	2.24e-05	0.000188	CcSEcCtD
Capecitabine—Flushing—Epirubicin—ovarian cancer	2.23e-05	0.000187	CcSEcCtD
Capecitabine—Cardiac disorder—Epirubicin—ovarian cancer	2.23e-05	0.000187	CcSEcCtD
Capecitabine—Rhinitis—Doxorubicin—ovarian cancer	2.23e-05	0.000187	CcSEcCtD
Capecitabine—Dyspepsia—Docetaxel—ovarian cancer	2.23e-05	0.000187	CcSEcCtD
Capecitabine—Hepatitis—Doxorubicin—ovarian cancer	2.23e-05	0.000187	CcSEcCtD
Capecitabine—Haemorrhage—Doxorubicin—ovarian cancer	2.23e-05	0.000187	CcSEcCtD
Capecitabine—Hypoaesthesia—Doxorubicin—ovarian cancer	2.22e-05	0.000186	CcSEcCtD
Capecitabine—Pharyngitis—Doxorubicin—ovarian cancer	2.21e-05	0.000185	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—TP53—ovarian cancer	2.21e-05	0.000774	CbGpPWpGaD
Capecitabine—Decreased appetite—Docetaxel—ovarian cancer	2.21e-05	0.000185	CcSEcCtD
Capecitabine—Hypersensitivity—Paclitaxel—ovarian cancer	2.2e-05	0.000185	CcSEcCtD
Capecitabine—Urinary tract disorder—Doxorubicin—ovarian cancer	2.2e-05	0.000184	CcSEcCtD
Capecitabine—Oedema peripheral—Doxorubicin—ovarian cancer	2.2e-05	0.000184	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Docetaxel—ovarian cancer	2.19e-05	0.000183	CcSEcCtD
Capecitabine—Connective tissue disorder—Doxorubicin—ovarian cancer	2.19e-05	0.000183	CcSEcCtD
Capecitabine—Fatigue—Docetaxel—ovarian cancer	2.19e-05	0.000183	CcSEcCtD
Capecitabine—Angiopathy—Epirubicin—ovarian cancer	2.18e-05	0.000183	CcSEcCtD
Capecitabine—Urethral disorder—Doxorubicin—ovarian cancer	2.18e-05	0.000183	CcSEcCtD
Capecitabine—Immune system disorder—Epirubicin—ovarian cancer	2.18e-05	0.000182	CcSEcCtD
Capecitabine—Mediastinal disorder—Epirubicin—ovarian cancer	2.17e-05	0.000182	CcSEcCtD
Capecitabine—Constipation—Docetaxel—ovarian cancer	2.17e-05	0.000182	CcSEcCtD
Capecitabine—Pain—Docetaxel—ovarian cancer	2.17e-05	0.000182	CcSEcCtD
Capecitabine—Chills—Epirubicin—ovarian cancer	2.16e-05	0.000181	CcSEcCtD
Capecitabine—Arrhythmia—Epirubicin—ovarian cancer	2.15e-05	0.00018	CcSEcCtD
Capecitabine—TYMS—Metabolism—YAP1—ovarian cancer	2.15e-05	0.000753	CbGpPWpGaD
Capecitabine—Visual impairment—Doxorubicin—ovarian cancer	2.15e-05	0.00018	CcSEcCtD
Capecitabine—Asthenia—Paclitaxel—ovarian cancer	2.15e-05	0.00018	CcSEcCtD
Capecitabine—Alopecia—Epirubicin—ovarian cancer	2.13e-05	0.000178	CcSEcCtD
Capecitabine—Pruritus—Paclitaxel—ovarian cancer	2.12e-05	0.000177	CcSEcCtD
Capecitabine—Mental disorder—Epirubicin—ovarian cancer	2.11e-05	0.000177	CcSEcCtD
Capecitabine—Erythema multiforme—Doxorubicin—ovarian cancer	2.11e-05	0.000176	CcSEcCtD
Capecitabine—Erythema—Epirubicin—ovarian cancer	2.1e-05	0.000176	CcSEcCtD
Capecitabine—Malnutrition—Epirubicin—ovarian cancer	2.1e-05	0.000176	CcSEcCtD
Capecitabine—Feeling abnormal—Docetaxel—ovarian cancer	2.09e-05	0.000175	CcSEcCtD
Capecitabine—Eye disorder—Doxorubicin—ovarian cancer	2.08e-05	0.000174	CcSEcCtD
Capecitabine—Tinnitus—Doxorubicin—ovarian cancer	2.08e-05	0.000174	CcSEcCtD
Capecitabine—Gastrointestinal pain—Docetaxel—ovarian cancer	2.07e-05	0.000174	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.07e-05	0.000727	CbGpPWpGaD
Capecitabine—Flushing—Doxorubicin—ovarian cancer	2.07e-05	0.000173	CcSEcCtD
Capecitabine—Cardiac disorder—Doxorubicin—ovarian cancer	2.07e-05	0.000173	CcSEcCtD
Capecitabine—Flatulence—Epirubicin—ovarian cancer	2.07e-05	0.000173	CcSEcCtD
Capecitabine—Dysgeusia—Epirubicin—ovarian cancer	2.05e-05	0.000172	CcSEcCtD
Capecitabine—Diarrhoea—Paclitaxel—ovarian cancer	2.05e-05	0.000172	CcSEcCtD
Capecitabine—CDA—Metabolism—PIK3CD—ovarian cancer	2.04e-05	0.000714	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CAV1—ovarian cancer	2.03e-05	0.000712	CbGpPWpGaD
Capecitabine—Back pain—Epirubicin—ovarian cancer	2.03e-05	0.00017	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—IL6—ovarian cancer	2.02e-05	0.000709	CbGpPWpGaD
Capecitabine—Angiopathy—Doxorubicin—ovarian cancer	2.02e-05	0.000169	CcSEcCtD
Capecitabine—Muscle spasms—Epirubicin—ovarian cancer	2.02e-05	0.000169	CcSEcCtD
Capecitabine—Immune system disorder—Doxorubicin—ovarian cancer	2.01e-05	0.000169	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—ovarian cancer	2.01e-05	0.000168	CcSEcCtD
Capecitabine—Body temperature increased—Docetaxel—ovarian cancer	2.01e-05	0.000168	CcSEcCtD
Capecitabine—Abdominal pain—Docetaxel—ovarian cancer	2.01e-05	0.000168	CcSEcCtD
Capecitabine—Chills—Doxorubicin—ovarian cancer	2e-05	0.000167	CcSEcCtD
Capecitabine—DPYD—Metabolism—PIK3CB—ovarian cancer	1.99e-05	0.000698	CbGpPWpGaD
Capecitabine—Arrhythmia—Doxorubicin—ovarian cancer	1.99e-05	0.000167	CcSEcCtD
Capecitabine—Dizziness—Paclitaxel—ovarian cancer	1.98e-05	0.000166	CcSEcCtD
Capecitabine—Vision blurred—Epirubicin—ovarian cancer	1.98e-05	0.000166	CcSEcCtD
Capecitabine—Alopecia—Doxorubicin—ovarian cancer	1.97e-05	0.000165	CcSEcCtD
Capecitabine—Mental disorder—Doxorubicin—ovarian cancer	1.95e-05	0.000164	CcSEcCtD
Capecitabine—Ill-defined disorder—Epirubicin—ovarian cancer	1.95e-05	0.000163	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.94e-05	0.000681	CbGpPWpGaD
Capecitabine—Malnutrition—Doxorubicin—ovarian cancer	1.94e-05	0.000162	CcSEcCtD
Capecitabine—Erythema—Doxorubicin—ovarian cancer	1.94e-05	0.000162	CcSEcCtD
Capecitabine—Anaemia—Epirubicin—ovarian cancer	1.94e-05	0.000162	CcSEcCtD
Capecitabine—Flatulence—Doxorubicin—ovarian cancer	1.91e-05	0.00016	CcSEcCtD
Capecitabine—Vomiting—Paclitaxel—ovarian cancer	1.9e-05	0.000159	CcSEcCtD
Capecitabine—Dysgeusia—Doxorubicin—ovarian cancer	1.9e-05	0.000159	CcSEcCtD
Capecitabine—Malaise—Epirubicin—ovarian cancer	1.89e-05	0.000158	CcSEcCtD
Capecitabine—Rash—Paclitaxel—ovarian cancer	1.89e-05	0.000158	CcSEcCtD
Capecitabine—Dermatitis—Paclitaxel—ovarian cancer	1.89e-05	0.000158	CcSEcCtD
Capecitabine—Vertigo—Epirubicin—ovarian cancer	1.88e-05	0.000158	CcSEcCtD
Capecitabine—Syncope—Epirubicin—ovarian cancer	1.88e-05	0.000157	CcSEcCtD
Capecitabine—Leukopenia—Epirubicin—ovarian cancer	1.88e-05	0.000157	CcSEcCtD
Capecitabine—Back pain—Doxorubicin—ovarian cancer	1.88e-05	0.000157	CcSEcCtD
Capecitabine—Headache—Paclitaxel—ovarian cancer	1.87e-05	0.000157	CcSEcCtD
Capecitabine—Hypersensitivity—Docetaxel—ovarian cancer	1.87e-05	0.000157	CcSEcCtD
Capecitabine—Muscle spasms—Doxorubicin—ovarian cancer	1.86e-05	0.000156	CcSEcCtD
Capecitabine—Palpitations—Epirubicin—ovarian cancer	1.85e-05	0.000155	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CG—ovarian cancer	1.85e-05	0.000649	CbGpPWpGaD
Capecitabine—Loss of consciousness—Epirubicin—ovarian cancer	1.84e-05	0.000154	CcSEcCtD
Capecitabine—Cough—Epirubicin—ovarian cancer	1.83e-05	0.000153	CcSEcCtD
Capecitabine—Vision blurred—Doxorubicin—ovarian cancer	1.83e-05	0.000153	CcSEcCtD
Capecitabine—Asthenia—Docetaxel—ovarian cancer	1.82e-05	0.000152	CcSEcCtD
Capecitabine—Hypertension—Epirubicin—ovarian cancer	1.81e-05	0.000152	CcSEcCtD
Capecitabine—Ill-defined disorder—Doxorubicin—ovarian cancer	1.8e-05	0.000151	CcSEcCtD
Capecitabine—Pruritus—Docetaxel—ovarian cancer	1.79e-05	0.00015	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—ovarian cancer	1.79e-05	0.00015	CcSEcCtD
Capecitabine—Chest pain—Epirubicin—ovarian cancer	1.78e-05	0.00015	CcSEcCtD
Capecitabine—Myalgia—Epirubicin—ovarian cancer	1.78e-05	0.00015	CcSEcCtD
Capecitabine—Arthralgia—Epirubicin—ovarian cancer	1.78e-05	0.00015	CcSEcCtD
Capecitabine—Anxiety—Epirubicin—ovarian cancer	1.78e-05	0.000149	CcSEcCtD
Capecitabine—Nausea—Paclitaxel—ovarian cancer	1.78e-05	0.000149	CcSEcCtD
Capecitabine—CDA—Metabolism—PIK3CB—ovarian cancer	1.77e-05	0.000622	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	1.77e-05	0.000621	CbGpPWpGaD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	1.77e-05	0.000148	CcSEcCtD
Capecitabine—Discomfort—Epirubicin—ovarian cancer	1.76e-05	0.000148	CcSEcCtD
Capecitabine—TYMS—Metabolism—FASN—ovarian cancer	1.75e-05	0.000614	CbGpPWpGaD
Capecitabine—Malaise—Doxorubicin—ovarian cancer	1.75e-05	0.000147	CcSEcCtD
Capecitabine—Dry mouth—Epirubicin—ovarian cancer	1.75e-05	0.000146	CcSEcCtD
Capecitabine—Vertigo—Doxorubicin—ovarian cancer	1.74e-05	0.000146	CcSEcCtD
Capecitabine—Syncope—Doxorubicin—ovarian cancer	1.74e-05	0.000146	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—ovarian cancer	1.74e-05	0.000145	CcSEcCtD
Capecitabine—Diarrhoea—Docetaxel—ovarian cancer	1.74e-05	0.000145	CcSEcCtD
Capecitabine—Confusional state—Epirubicin—ovarian cancer	1.73e-05	0.000145	CcSEcCtD
Capecitabine—TYMS—Metabolism—SLC5A5—ovarian cancer	1.72e-05	0.000604	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTEN—ovarian cancer	1.72e-05	0.000603	CbGpPWpGaD
Capecitabine—Palpitations—Doxorubicin—ovarian cancer	1.71e-05	0.000144	CcSEcCtD
Capecitabine—Oedema—Epirubicin—ovarian cancer	1.71e-05	0.000143	CcSEcCtD
Capecitabine—Loss of consciousness—Doxorubicin—ovarian cancer	1.7e-05	0.000143	CcSEcCtD
Capecitabine—Infection—Epirubicin—ovarian cancer	1.7e-05	0.000142	CcSEcCtD
Capecitabine—Cough—Doxorubicin—ovarian cancer	1.69e-05	0.000142	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—ovarian cancer	1.69e-05	0.000593	CbGpPWpGaD
Capecitabine—Shock—Epirubicin—ovarian cancer	1.68e-05	0.000141	CcSEcCtD
Capecitabine—Nervous system disorder—Epirubicin—ovarian cancer	1.68e-05	0.000141	CcSEcCtD
Capecitabine—Dizziness—Docetaxel—ovarian cancer	1.68e-05	0.000141	CcSEcCtD
Capecitabine—Thrombocytopenia—Epirubicin—ovarian cancer	1.68e-05	0.00014	CcSEcCtD
Capecitabine—Hypertension—Doxorubicin—ovarian cancer	1.67e-05	0.00014	CcSEcCtD
Capecitabine—Tachycardia—Epirubicin—ovarian cancer	1.67e-05	0.00014	CcSEcCtD
Capecitabine—TYMS—Metabolism—SLC2A1—ovarian cancer	1.66e-05	0.000583	CbGpPWpGaD
Capecitabine—Skin disorder—Epirubicin—ovarian cancer	1.66e-05	0.000139	CcSEcCtD
Capecitabine—Hyperhidrosis—Epirubicin—ovarian cancer	1.65e-05	0.000139	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—ovarian cancer	1.65e-05	0.000138	CcSEcCtD
Capecitabine—Myalgia—Doxorubicin—ovarian cancer	1.65e-05	0.000138	CcSEcCtD
Capecitabine—Chest pain—Doxorubicin—ovarian cancer	1.65e-05	0.000138	CcSEcCtD
Capecitabine—Anxiety—Doxorubicin—ovarian cancer	1.65e-05	0.000138	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	1.64e-05	0.000137	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—NME2—ovarian cancer	1.64e-05	0.000575	CbGpPWpGaD
Capecitabine—Discomfort—Doxorubicin—ovarian cancer	1.63e-05	0.000137	CcSEcCtD
Capecitabine—Anorexia—Epirubicin—ovarian cancer	1.63e-05	0.000137	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CD—ovarian cancer	1.63e-05	0.00057	CbGpPWpGaD
Capecitabine—Dry mouth—Doxorubicin—ovarian cancer	1.62e-05	0.000135	CcSEcCtD
Capecitabine—Vomiting—Docetaxel—ovarian cancer	1.61e-05	0.000135	CcSEcCtD
Capecitabine—Rash—Docetaxel—ovarian cancer	1.6e-05	0.000134	CcSEcCtD
Capecitabine—Hypotension—Epirubicin—ovarian cancer	1.6e-05	0.000134	CcSEcCtD
Capecitabine—Dermatitis—Docetaxel—ovarian cancer	1.6e-05	0.000134	CcSEcCtD
Capecitabine—Confusional state—Doxorubicin—ovarian cancer	1.6e-05	0.000134	CcSEcCtD
Capecitabine—TYMS—Metabolism—CYP1B1—ovarian cancer	1.6e-05	0.000559	CbGpPWpGaD
Capecitabine—Headache—Docetaxel—ovarian cancer	1.59e-05	0.000133	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN1B—ovarian cancer	1.59e-05	0.000556	CbGpPWpGaD
Capecitabine—Oedema—Doxorubicin—ovarian cancer	1.58e-05	0.000133	CcSEcCtD
Capecitabine—Infection—Doxorubicin—ovarian cancer	1.57e-05	0.000132	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.56e-05	0.000131	CcSEcCtD
Capecitabine—Shock—Doxorubicin—ovarian cancer	1.56e-05	0.00013	CcSEcCtD
Capecitabine—Nervous system disorder—Doxorubicin—ovarian cancer	1.55e-05	0.00013	CcSEcCtD
Capecitabine—Thrombocytopenia—Doxorubicin—ovarian cancer	1.55e-05	0.00013	CcSEcCtD
Capecitabine—Insomnia—Epirubicin—ovarian cancer	1.55e-05	0.00013	CcSEcCtD
Capecitabine—Tachycardia—Doxorubicin—ovarian cancer	1.55e-05	0.000129	CcSEcCtD
Capecitabine—Skin disorder—Doxorubicin—ovarian cancer	1.54e-05	0.000129	CcSEcCtD
Capecitabine—Paraesthesia—Epirubicin—ovarian cancer	1.54e-05	0.000129	CcSEcCtD
Capecitabine—CDA—Metabolism—PTEN—ovarian cancer	1.53e-05	0.000537	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Doxorubicin—ovarian cancer	1.53e-05	0.000128	CcSEcCtD
Capecitabine—Dyspnoea—Epirubicin—ovarian cancer	1.53e-05	0.000128	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CCND1—ovarian cancer	1.51e-05	0.00053	CbGpPWpGaD
Capecitabine—Anorexia—Doxorubicin—ovarian cancer	1.51e-05	0.000126	CcSEcCtD
Capecitabine—Nausea—Docetaxel—ovarian cancer	1.51e-05	0.000126	CcSEcCtD
Capecitabine—Dyspepsia—Epirubicin—ovarian cancer	1.51e-05	0.000126	CcSEcCtD
Capecitabine—Decreased appetite—Epirubicin—ovarian cancer	1.49e-05	0.000125	CcSEcCtD
Capecitabine—Hypotension—Doxorubicin—ovarian cancer	1.48e-05	0.000124	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.48e-05	0.000124	CcSEcCtD
Capecitabine—Fatigue—Epirubicin—ovarian cancer	1.48e-05	0.000124	CcSEcCtD
Capecitabine—Constipation—Epirubicin—ovarian cancer	1.46e-05	0.000123	CcSEcCtD
Capecitabine—Pain—Epirubicin—ovarian cancer	1.46e-05	0.000123	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.44e-05	0.000121	CcSEcCtD
Capecitabine—Insomnia—Doxorubicin—ovarian cancer	1.43e-05	0.00012	CcSEcCtD
Capecitabine—Paraesthesia—Doxorubicin—ovarian cancer	1.42e-05	0.000119	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CB—ovarian cancer	1.42e-05	0.000497	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPP2R1A—ovarian cancer	1.42e-05	0.000496	CbGpPWpGaD
Capecitabine—Dyspnoea—Doxorubicin—ovarian cancer	1.41e-05	0.000118	CcSEcCtD
Capecitabine—Feeling abnormal—Epirubicin—ovarian cancer	1.41e-05	0.000118	CcSEcCtD
Capecitabine—Gastrointestinal pain—Epirubicin—ovarian cancer	1.4e-05	0.000117	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.39e-05	0.000489	CbGpPWpGaD
Capecitabine—Dyspepsia—Doxorubicin—ovarian cancer	1.39e-05	0.000117	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.39e-05	0.000487	CbGpPWpGaD
Capecitabine—Decreased appetite—Doxorubicin—ovarian cancer	1.38e-05	0.000115	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.37e-05	0.000114	CcSEcCtD
Capecitabine—Fatigue—Doxorubicin—ovarian cancer	1.36e-05	0.000114	CcSEcCtD
Capecitabine—Urticaria—Epirubicin—ovarian cancer	1.36e-05	0.000114	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—ovarian cancer	1.36e-05	0.000475	CbGpPWpGaD
Capecitabine—Constipation—Doxorubicin—ovarian cancer	1.35e-05	0.000113	CcSEcCtD
Capecitabine—Pain—Doxorubicin—ovarian cancer	1.35e-05	0.000113	CcSEcCtD
Capecitabine—Body temperature increased—Epirubicin—ovarian cancer	1.35e-05	0.000113	CcSEcCtD
Capecitabine—Abdominal pain—Epirubicin—ovarian cancer	1.35e-05	0.000113	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.33e-05	0.000465	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCB1—ovarian cancer	1.31e-05	0.00046	CbGpPWpGaD
Capecitabine—Feeling abnormal—Doxorubicin—ovarian cancer	1.3e-05	0.000109	CcSEcCtD
Capecitabine—Gastrointestinal pain—Doxorubicin—ovarian cancer	1.29e-05	0.000108	CcSEcCtD
Capecitabine—Hypersensitivity—Epirubicin—ovarian cancer	1.26e-05	0.000106	CcSEcCtD
Capecitabine—Urticaria—Doxorubicin—ovarian cancer	1.26e-05	0.000105	CcSEcCtD
Capecitabine—Body temperature increased—Doxorubicin—ovarian cancer	1.25e-05	0.000105	CcSEcCtD
Capecitabine—Abdominal pain—Doxorubicin—ovarian cancer	1.25e-05	0.000105	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—MAPK3—ovarian cancer	1.25e-05	0.000437	CbGpPWpGaD
Capecitabine—Asthenia—Epirubicin—ovarian cancer	1.23e-05	0.000103	CcSEcCtD
Capecitabine—TYMP—Metabolism—PTEN—ovarian cancer	1.23e-05	0.00043	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—ovarian cancer	1.21e-05	0.000425	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—ovarian cancer	1.21e-05	0.000425	CbGpPWpGaD
Capecitabine—Pruritus—Epirubicin—ovarian cancer	1.21e-05	0.000101	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—MAPK1—ovarian cancer	1.19e-05	0.000416	CbGpPWpGaD
Capecitabine—Diarrhoea—Epirubicin—ovarian cancer	1.17e-05	9.81e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Doxorubicin—ovarian cancer	1.17e-05	9.77e-05	CcSEcCtD
Capecitabine—Asthenia—Doxorubicin—ovarian cancer	1.14e-05	9.51e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.13e-05	0.000397	CbGpPWpGaD
Capecitabine—Dizziness—Epirubicin—ovarian cancer	1.13e-05	9.48e-05	CcSEcCtD
Capecitabine—Pruritus—Doxorubicin—ovarian cancer	1.12e-05	9.38e-05	CcSEcCtD
Capecitabine—Vomiting—Epirubicin—ovarian cancer	1.09e-05	9.11e-05	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—ovarian cancer	1.08e-05	9.07e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PIK3CA—ovarian cancer	1.08e-05	0.000379	CbGpPWpGaD
Capecitabine—Rash—Epirubicin—ovarian cancer	1.08e-05	9.04e-05	CcSEcCtD
Capecitabine—Dermatitis—Epirubicin—ovarian cancer	1.08e-05	9.03e-05	CcSEcCtD
Capecitabine—Headache—Epirubicin—ovarian cancer	1.07e-05	8.98e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CYTB—ovarian cancer	1.06e-05	0.00037	CbGpPWpGaD
Capecitabine—Dizziness—Doxorubicin—ovarian cancer	1.05e-05	8.77e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CAV1—ovarian cancer	1.04e-05	0.000364	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.03e-05	0.000362	CbGpPWpGaD
Capecitabine—Nausea—Epirubicin—ovarian cancer	1.02e-05	8.51e-05	CcSEcCtD
Capecitabine—Vomiting—Doxorubicin—ovarian cancer	1.01e-05	8.43e-05	CcSEcCtD
Capecitabine—Rash—Doxorubicin—ovarian cancer	9.98e-06	8.36e-05	CcSEcCtD
Capecitabine—Dermatitis—Doxorubicin—ovarian cancer	9.97e-06	8.35e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TP53—ovarian cancer	9.96e-06	0.000349	CbGpPWpGaD
Capecitabine—Headache—Doxorubicin—ovarian cancer	9.92e-06	8.31e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—AKT1—ovarian cancer	9.92e-06	0.000347	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CG—ovarian cancer	9.47e-06	0.000332	CbGpPWpGaD
Capecitabine—Nausea—Doxorubicin—ovarian cancer	9.4e-06	7.88e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—BRIP1—ovarian cancer	9.24e-06	0.000324	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPP1CC—ovarian cancer	9.24e-06	0.000324	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—ovarian cancer	8.84e-06	0.00031	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CA—ovarian cancer	8.65e-06	0.000303	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CD—ovarian cancer	8.33e-06	0.000292	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CB—ovarian cancer	7.26e-06	0.000254	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—ovarian cancer	7.07e-06	0.000248	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.73e-06	0.000236	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTEN—ovarian cancer	6.27e-06	0.00022	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—YAP1—ovarian cancer	6.19e-06	0.000217	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.13e-06	0.000215	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.39e-06	0.000189	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—FASN—ovarian cancer	5.05e-06	0.000177	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.97e-06	0.000174	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.8e-06	0.000168	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.7e-06	0.000165	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.6e-06	0.000161	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—ovarian cancer	4.42e-06	0.000155	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.08e-06	0.000143	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.06e-06	0.000142	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.79e-06	0.000133	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TYMS—ovarian cancer	3.72e-06	0.00013	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—ovarian cancer	3.61e-06	0.000127	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CAV1—ovarian cancer	3e-06	0.000105	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.86e-06	0.0001	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.73e-06	9.57e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.4e-06	8.41e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.09e-06	7.33e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—ovarian cancer	1.81e-06	6.34e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.28e-06	4.47e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.04e-06	3.65e-05	CbGpPWpGaD
